search
Back to results

Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa

Primary Purpose

Human Immunodeficiency Virus

Status
Active
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
START Together
Sponsored by
University of Maryland, College Park
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Human Immunodeficiency Virus focused on measuring Couple-based intervention, Antiretroviral therapy, South Africa

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Both partners aged 18 or over
  • HIV-positive woman diagnosed ≥ 3 months prior to study entry
  • HIV-positive woman demonstrates difficulty with HIV treatment engagement, defined as either self-reported ART adherence difficulties, evidence of missed clinic visits over the past year (collected from medical records), or evidence of being not virally suppressed (≥ 50 copies/mL) in the past year
  • In a committed, heterosexual, monogamous romantic relationship for at least 6 months
  • Both partners willing to participate in treatment to support women's ART adherence
  • Both partners reside in Vulindlela, or neighboring community, KwaZulu-Natal, South Africa
  • Willing to have intervention sessions audio-recorded (if randomized to the intervention group)
  • Able to comfortably communicate in either isiZulu or English

Exclusion Criteria:

  • Report of moderate or severe relationship violence past year
  • Either partner previously participated in a couple-based HIV prevention or treatment program

Sites / Locations

  • Human Sciences Research Council

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

START Together

Standard of Care (SOC)

Arm Description

Couples randomized to START Together will receive the manualized treatment to enhance women's medication adherence. The treatment is 5 sessions in length and conducted weekly. Sessions are 60 - 75 minutes. Couples have the option of completing up to 3 additional booster sessions. Total treatment therefore ranges between 5 to 8 sessions.

Couples randomized to SOC will receive referrals to local HIV clinics to support medication adherence (for women) or other HIV-related issues (for men).

Outcomes

Primary Outcome Measures

Percentage of couples assigned to START Together who agree to enroll in the intervention
Feasibility of START Together intervention
Average score on the 14-item Applied Mental Health Research group's feasibility subscale
Feasibility of START Together intervention. Higher scores indicate greater feasibility.
Percentage of couples assigned to START Together who complete all treatment sessions
Acceptability of START Together intervention
Average number of START Together sessions attended
Acceptability of START Together intervention
Average score on the 15-item Applied Mental Health Research group's acceptability subscale
Acceptability of START Together intervention. Higher scores indicate greater acceptability.
Average percentage of session content and process items that were completed correctly by the interventionist
START Together intervention fidelity

Secondary Outcome Measures

Viral suppression for women
Viral load in dried blood spots or based on clinic records (past 30 days)
HIV medication adherence for women
Self-report using the Ira Wilson adherence measure. Higher scores indicate better adherence
HIV medication adherence for women
Self-report using the Ira Wilson adherence measure. Higher scores indicate better adherence
Engagement in HIV care for men
Dichotomous engagement in care (yes/no) will be measured by clinic records review. If clinic records are unavailable, participant self-report will be used.
Relationship functioning (women and men)
Total score and subscales (relationship building, open communication, and couple-level problem-solving) of the South Africa Healthy Relationships Questionnaire. Higher scores indicate better relationship functioning.
Relationship functioning (women and men)
Total score and subscales (relationship building, open communication, and couple-level problem-solving) of the South Africa Healthy Relationships Questionnaire. Higher scores indicate better relationship functioning.

Full Information

First Posted
January 9, 2019
Last Updated
November 9, 2022
Sponsor
University of Maryland, College Park
Collaborators
Human Sciences Research Council, University of Washington, Canadian Institutes of Health Research (CIHR), Swiss Tropical & Public Health Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT03809364
Brief Title
Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa
Official Title
Supporting Treatment for Anti-Retroviral Therapy (START) Together: Development of a Couple-based Medication Adherence Intervention for HIV-positive Women and Their Male Partners in Sweetwaters, South Africa
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 1, 2021 (Actual)
Primary Completion Date
October 11, 2022 (Actual)
Study Completion Date
December 15, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, College Park
Collaborators
Human Sciences Research Council, University of Washington, Canadian Institutes of Health Research (CIHR), Swiss Tropical & Public Health Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to collect quantitative data related to developing and testing a couple-based intervention (CBI) for HIV-positive women's medication adherence in the region of Kwazulu-Natal, South Africa. The CBI, called START (Supporting Treatment for Anti-Retroviral Therapy) Together, will be a manualized intervention focused on women's ART adherence and enhancing the couple's communication and problem-solving behavior. The study focuses on implementation outcomes (feasibility, acceptability, and fidelity) and preliminary efficacy outcomes (women's ART adherence, men's engagement in HIV care, and the couple's relationship functioning), which will be compared to a control condition of referrals to usual HIV care.
Detailed Description
South Africa (SA) has one of the highest global HIV burdens with clear gender disparities. For men, 57% of HIV-related deaths occur among persons who have never sought HIV care. Women, in comparison, have high rates of HIV testing and are linked to care through antenatal services, but only 45% are virally suppressed on antiretroviral therapy (ART). Thus, tailored interventions for HIV are needed. In order to end the AIDS epidemic, the ambitious "90-90-90" goal was developed by UNAIDS to test, treat, and maintain medication adherence for 73% of HIV-positive individuals. Separate gender-specific interventions have been developed along the HIV care cascade to treat the different needs of men and women. However, no study to date has used one intervention to concurrently meet the unique HIV-related needs for women and men. Couple-based interventions (CBIs) can achieve this goal. CBIs are more efficacious than interventions delivered to individuals in enhancing a number of HIV protective behaviors. HIV is also primarily transmitted in the context of stable heterosexual relationships in sub-Saharan Africa; about 50% of new infections occur in serodiscordant relationships, making the use of a CBI especially relevant. The purpose of this study is to strengthen the HIV care cascade in SA by developing a CBI that concurrently addresses the needs of women and men to meet the UNAIDS' HIV goals. This study will be conducted in the province of KwaZulu-Natal, SA. HIV-positive women who are in a heterosexual relationship and non-adherent to ART will be recruited to participate in the study with their male partners. Twenty couples will be recruited and randomized to either receive the START Together program or to the control condition and followed for 12 weeks thereafter.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Human Immunodeficiency Virus
Keywords
Couple-based intervention, Antiretroviral therapy, South Africa

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
START Together
Arm Type
Experimental
Arm Description
Couples randomized to START Together will receive the manualized treatment to enhance women's medication adherence. The treatment is 5 sessions in length and conducted weekly. Sessions are 60 - 75 minutes. Couples have the option of completing up to 3 additional booster sessions. Total treatment therefore ranges between 5 to 8 sessions.
Arm Title
Standard of Care (SOC)
Arm Type
No Intervention
Arm Description
Couples randomized to SOC will receive referrals to local HIV clinics to support medication adherence (for women) or other HIV-related issues (for men).
Intervention Type
Behavioral
Intervention Name(s)
START Together
Intervention Description
Behavioral intervention using a cognitive behavioral couple therapy (CBCT) framework designed to improve the couple's communication and problem-solving behavior.
Primary Outcome Measure Information:
Title
Percentage of couples assigned to START Together who agree to enroll in the intervention
Description
Feasibility of START Together intervention
Time Frame
Approximately 8 weeks post-randomization
Title
Average score on the 14-item Applied Mental Health Research group's feasibility subscale
Description
Feasibility of START Together intervention. Higher scores indicate greater feasibility.
Time Frame
Approximately 8 weeks post-randomization
Title
Percentage of couples assigned to START Together who complete all treatment sessions
Description
Acceptability of START Together intervention
Time Frame
Approximately 8 weeks post-randomization
Title
Average number of START Together sessions attended
Description
Acceptability of START Together intervention
Time Frame
Approximately 8 weeks post-randomization
Title
Average score on the 15-item Applied Mental Health Research group's acceptability subscale
Description
Acceptability of START Together intervention. Higher scores indicate greater acceptability.
Time Frame
Approximately 8 weeks post-randomization
Title
Average percentage of session content and process items that were completed correctly by the interventionist
Description
START Together intervention fidelity
Time Frame
Approximately 8 weeks post-randomization
Secondary Outcome Measure Information:
Title
Viral suppression for women
Description
Viral load in dried blood spots or based on clinic records (past 30 days)
Time Frame
Change from baseline assessment to approximately 12 weeks post-randomization
Title
HIV medication adherence for women
Description
Self-report using the Ira Wilson adherence measure. Higher scores indicate better adherence
Time Frame
Change from baseline assessment to approximately 8 weeks post-randomization
Title
HIV medication adherence for women
Description
Self-report using the Ira Wilson adherence measure. Higher scores indicate better adherence
Time Frame
Change from baseline assessment to approximately 12 weeks post-randomization
Title
Engagement in HIV care for men
Description
Dichotomous engagement in care (yes/no) will be measured by clinic records review. If clinic records are unavailable, participant self-report will be used.
Time Frame
Change from baseline assessment to approximately 12 weeks post-randomization
Title
Relationship functioning (women and men)
Description
Total score and subscales (relationship building, open communication, and couple-level problem-solving) of the South Africa Healthy Relationships Questionnaire. Higher scores indicate better relationship functioning.
Time Frame
Change from baseline assessment to approximately 8 weeks post-randomization
Title
Relationship functioning (women and men)
Description
Total score and subscales (relationship building, open communication, and couple-level problem-solving) of the South Africa Healthy Relationships Questionnaire. Higher scores indicate better relationship functioning.
Time Frame
Change from baseline assessment to approximately 12 weeks post-randomization

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
HIV-positive women are the target study participants. They will participate in treatment with their male partners.
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Both partners aged 18 or over HIV-positive woman diagnosed ≥ 3 months prior to study entry HIV-positive woman demonstrates difficulty with HIV treatment engagement, defined as either self-reported ART adherence difficulties, evidence of missed clinic visits over the past year (collected from medical records), or evidence of being not virally suppressed (≥ 50 copies/mL) in the past year In a committed, heterosexual, monogamous romantic relationship for at least 6 months Both partners willing to participate in treatment to support women's ART adherence Both partners reside in Vulindlela, or neighboring community, KwaZulu-Natal, South Africa Willing to have intervention sessions audio-recorded (if randomized to the intervention group) Able to comfortably communicate in either isiZulu or English Exclusion Criteria: Report of moderate or severe relationship violence past year Either partner previously participated in a couple-based HIV prevention or treatment program
Facility Information:
Facility Name
Human Sciences Research Council
City
Pietermaritzburg
State/Province
KwaZulu-Natal
Country
South Africa

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26608175
Citation
Crepaz N, Tungol-Ashmon MV, Vosburgh HW, Baack BN, Mullins MM. Are couple-based interventions more effective than interventions delivered to individuals in promoting HIV protective behaviors? A meta-analysis. AIDS Care. 2015;27(11):1361-6. doi: 10.1080/09540121.2015.1112353. Epub 2015 Nov 25.
Results Reference
background
PubMed Identifier
24129466
Citation
Anglemyer A, Horvath T, Rutherford G. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. JAMA. 2013 Oct 16;310(15):1619-20. doi: 10.1001/jama.2013.278328.
Results Reference
background
PubMed Identifier
26599699
Citation
Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, Tanser F, Pillay D, Barnighausen T. Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa. PLoS Med. 2015 Nov 24;12(11):e1001905; discussion e1001905. doi: 10.1371/journal.pmed.1001905. eCollection 2015 Nov.
Results Reference
background

Learn more about this trial

Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa

We'll reach out to this number within 24 hrs